STUDY OBJECTIVES: The most recent idiopathic pulmonary fibrosis (IPF) guidelines include obstructive sleep apnea (OSA) among the IPF-associated comorbidities. Furthermore, they recognize the paucity of studies related to continuous positive airway pressure(CPAP) treatment in this patient group and call for intensive research in this field. Our aim was to assess the effect of CPAP treatment on sleep and overall life quality parameters, morbidity, and mortality in IPF patients with OSA. METHODS: Ninety-two treatment-naive, newly diagnosed, consecutive IPF patients underwent overnight-attended polysomnography (PSG). In those patients with an apnea-hypopnea index (AHI) of ≥15, therapy with CPAP was initiated. Patients were divided into poor and good CPAP compliance groups. All subjects completed multiple quality-of-life and sleep instruments before CPAP initiation and at 1 year after the start of CPAP treatment. RESULTS: The good CPAP compliance group (37 patients) showed statistically significant improvement in all quality-of-life and sleep instruments after 1 year's CPAP treatment. The poor CPAP compliance group (18 patients) showed significant changes of smaller strength only in a minority of the used instruments. During the 24-month follow-up period after CPAP initiation, three patients from the CPAP poor compliance group died, whereas all patients from the good CPAP compliance group remained alive. CONCLUSION: Early OSA recognition and treatment is crucial in a fatal disease such as IPF. Effective CPAP treatment in IPF patients with OSA results in a significant improvement in daily living activities and quality of sleep and life. Good CPAP compliance appears to improve mortality.
STUDY OBJECTIVES: The most recent idiopathic pulmonary fibrosis (IPF) guidelines include obstructive sleep apnea (OSA) among the IPF-associated comorbidities. Furthermore, they recognize the paucity of studies related to continuous positive airway pressure(CPAP) treatment in this patient group and call for intensive research in this field. Our aim was to assess the effect of CPAP treatment on sleep and overall life quality parameters, morbidity, and mortality in IPFpatients with OSA. METHODS: Ninety-two treatment-naive, newly diagnosed, consecutive IPFpatients underwent overnight-attended polysomnography (PSG). In those patients with an apnea-hypopnea index (AHI) of ≥15, therapy with CPAP was initiated. Patients were divided into poor and good CPAP compliance groups. All subjects completed multiple quality-of-life and sleep instruments before CPAP initiation and at 1 year after the start of CPAP treatment. RESULTS: The good CPAP compliance group (37 patients) showed statistically significant improvement in all quality-of-life and sleep instruments after 1 year's CPAP treatment. The poor CPAP compliance group (18 patients) showed significant changes of smaller strength only in a minority of the used instruments. During the 24-month follow-up period after CPAP initiation, three patients from the CPAP poor compliance group died, whereas all patients from the good CPAP compliance group remained alive. CONCLUSION: Early OSA recognition and treatment is crucial in a fatal disease such as IPF. Effective CPAP treatment in IPFpatients with OSA results in a significant improvement in daily living activities and quality of sleep and life. Good CPAP compliance appears to improve mortality.
Authors: Steven D Nathan; Oksana A Shlobin; Nargues Weir; Shahzad Ahmad; Julienne M Kaldjob; Edwinia Battle; Michael J Sheridan; Roland M du Bois Journal: Chest Date: 2011-07 Impact factor: 9.410
Authors: C Mermigkis; A Kopanakis; N Foldvary-Schaefer; J Golish; V Polychronopoulos; S Schiza; A Amfilochiou; N Siafakas; D Bouros Journal: Int J Clin Pract Date: 2007-02 Impact factor: 2.503
Authors: Vidya Krishnan; Meredith C McCormack; Stephen C Mathai; Shikhar Agarwal; Brittany Richardson; Maureen R Horton; Albert J Polito; Nancy A Collop; Sonye K Danoff Journal: Chest Date: 2008-07-14 Impact factor: 9.410
Authors: Xiao Lei Zhang; Hua Ping Dai; Hui Zhang; Bo Gao; Li Zhang; Teng Han; Chen Wang Journal: J Clin Sleep Med Date: 2019-10-26 Impact factor: 4.062
Authors: Ayodeji Adegunsoye; Julie M Neborak; Daisy Zhu; Benjamin Cantrill; Nicole Garcia; Justin M Oldham; Imre Noth; Rekha Vij; Tomasz J Kuzniar; Shashi K Bellam; Mary E Strek; Babak Mokhlesi Journal: Chest Date: 2020-05-22 Impact factor: 9.410
Authors: Rudolf K Braun; Oleg Broytman; Felix M Braun; Jacqueline A Brinkman; Andrew Clithero; Dhruvangkumar Modi; David F Pegelow; Marlowe Eldridge; Mihaela Teodorescu Journal: Respir Physiol Neurobiol Date: 2017-04-27 Impact factor: 1.931